Advaxis Reports Second Quarter Ended April 30, 2022 Financial Results and Provides a Business Update

Provided By Globe Newswire

Last update: Jun 8, 2022

Announced Publication of ADXS-PSA Data in The Oncologist

Presented Updated Clinical and Immunogenicity Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting